POP star Lizzo has claimed plus-size women are being “erased” as society grapples with the impact of the “Ozempic boom.” The ...
Lizzo is opening up about her darkest moments, and calling out the Ozempic era and the fading visibility of bigger bodies.
14hon MSN
Lizzo gets personal about feeling 'deeply suicidal' before weight loss journey and 'ozempic boom'
Lizzo opened up in a new personal essay about her mental health struggles before going on her weight loss journey and the ...
Lizzo is opening up about the reasoning behind her weight loss journey, insisting she still loves being a "big girl" amid the ...
The Financial Express on MSN
Novo Nordisk stock plunges to a four-year-low. Here is the reason behind the slump
Novo Nordisk shares plunge after semaglutide Alzheimer’s trial fails to meet its main goal, deepening pressure amid ...
Lizzo, whose appearance has been the subject of public scrutiny, opened up about her weight-loss journey in an emotional ...
In a raw essay, Lizzo reveals her depression battle and fears that big girls are disappearing from Hollywood’s spotlight.
Like an estimated 20 million Americans, I have an incurable post-acute infection syndrome that goes by the name of long Covid ...
Parade on MSN
Lizzo Gets Candid About Struggles During Weight Loss Journey After Shedding 16% Body Fat
The 37-year-old 'Truth Hurts' singer shared that she was 'severely depressed' at the start of her transformation.
Complex on MSNOpinion
Lizzo Says Plus-Sized Women Are Being 'Erased' Due to Ozempic Boom
The Grammy winner opened up about how the rise of GLP-1 drugs is changing visibility for women who look like her.
Shares Danish pharma major Novo Nordisk were down 9.5% at 275.80 kroner today, after it announced disappointing top-line ...
We felt we had a responsibility to explore semaglutide’s potential, despite a low likelihood of success,” Martin Holst Lange, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results